Triple negative breast cancer (TNBC): Non-genetic tumor heterogeneity and immune microenvironment: Emerging treatment options-Reference-Cited by-同舟云学术

Triple negative breast cancer (TNBC): Non-genetic tumor heterogeneity and immune microenvironment: Emerging treatment options

Published:2022-09 Issue: Volume:237 Page:108253
ISSN:0163-7258
Container-title:Pharmacology & Therapeutics
language:en
Short-container-title:Pharmacology & Therapeutics

Author:

So Jae Young,Ohm Joyce,Lipkowitz Stan,Yang Li

Funder

National Cancer Institute

Government of South Australia

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference113 articles.

1. HAGE in triple-negative breast cancer is a novel prognostic, predictive, and actionable biomarker: A transcriptomic and protein expression analysis;Abdel-Fatah;Clinical Cancer Research,2016

2. Pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: Cohort A of the phase II KEYNOTE-086 study;Adams;Annals of Oncology,2019

3. Signatures of mutational processes in human cancer;Alexandrov;Nature,2013

4. The genomic landscape of metastatic breast cancer highlights changes in mutation and signature frequencies;Angus;Nature Genetics,2019

5. New data for sacituzumab govitecan-hziy in the treatment of metastatic triple-negative breast cancer;Bardia;Clinical Advances in Hematology & Oncology,2021

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transcriptional regulation of DLGAP5 by AR suppresses p53 signaling and inhibits CD8+ T cell infiltration in triple-negative breast cancer;Translational Oncology;2024-11

2. Effect of tumor-derived extracellular vesicle-shuttled lncRNA MALAT1 on proliferation, invasion and metastasis of triple-negative breast cancer by regulating macrophage M2 polarization via the POSTN/Hippo/YAP axis;Translational Oncology;2024-11

3. Non-invasive prediction of axillary lymph node dissection exemption in breast cancer patients post-neoadjuvant therapy: A radiomics and deep learning analysis on longitudinal DCE-MRI data;The Breast;2024-10

4. Charge-Reversal Nano-Drug Delivery Systems in the Tumor Microenvironment: Mechanisms, Challenges, and Therapeutic Applications;International Journal of Molecular Sciences;2024-09-10

5. PCMT1 as a prognostic marker in breast cancer;Clinical and Translational Oncology;2024-09-05